![Ehud Geller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ehud Geller
Vorstandsvorsitzender bei
REGENTIS BIOMATERIALS LTD.
Vermögen: 948 556 $ am 31.05.2026
Profil
Ehud Geller is the founder of Medica Venture Partners, established in 1995, serving as Managing Partner.
Current jobs include Executive Chairman & Chief Executive Officer at Regentis Biomaterials Ltd. starting in 2025, Chairman at Gardia Medical Ltd., Executive Chairman at PRF Technologies Ltd. starting in 2026, and Director roles at Medica III Management Co., Zori Medica 3 Ltd., Zori Medica (2010) Ltd., Tzory Medica (Management) Israel Ltd., A.G.
Arhimedes Ltd., Zori Medica (Management) Israel Ltd., and A.D.
Geller Enterprises Ltd. Former jobs include President & Chief Executive Officer at Interpharm Laboratories Ltd. from 1985 to 1990, Director positions at GlobeImmune, Inc., Yissum Research Development Co. Ltd., Sol-Gel Technologies Ltd., InterCure Ltd., Collgard Biopharmaceuticals Ltd., Vidyatel Ltd., The Tel Aviv Stock Exchange (Investment Management), and Allmed Solutions Ltd. from 2012 to 2020, Executive VP & President-Pharmaceutical Division at Teva Pharmaceutical Industries Ltd. from 1979 to 1985, and Senior Research Scientist at Wyeth Laboratories, Inc. Education includes an MBA and doctorate from Drexel University in 1975, and an undergraduate degree and MBA from The Trustees of Columbia University in The City of New York in 1970.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 512.733 ( 9,9 % ) | 948 556 $ | 31.05.2026 | |
| 18.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Ehud Geller
| Unternehmen | Position | Beginn |
|---|---|---|
| PRF TECHNOLOGIES LTD. | Vorsitzender | 01.11.2008 |
| REGENTIS BIOMATERIALS LTD. | Vorstandsvorsitzender | 31.12.2025 |
Medica Venture Partners
 Medica Venture Partners Investment ManagersFinance Medica Ventures Partners invests in public and private companies located in Israel, Europe and the United States. The firm focuses on health care and life science technologies from medical devices to pharmaceuticals, biotech and genomics sectors. It provides financing for seed and early stage capital requirements. | Gründer | 01.04.1995 |
Medica III Management Co. | Direktor/Vorstandsmitglied | - |
A.D. Geller Enterprises Ltd. | Direktor/Vorstandsmitglied | - |
Zori Medica (Management) Israel Ltd. | Direktor/Vorstandsmitglied | - |
A.G. Arhimedes Ltd. | Direktor/Vorstandsmitglied | - |
Tzory Medica (Management) Israel Ltd. | Direktor/Vorstandsmitglied | - |
Zori Medica (2010) Ltd. | Direktor/Vorstandsmitglied | - |
| ░░░░ ░░░░░░ ░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Ehud Geller
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Ehud Geller
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
24
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 24 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
GlobeImmune, Inc.
 GlobeImmune, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for cancer and infectious diseases | Health Technology |
Medica III Management Co. | |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research invests in companies located in Israel. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sol-Gel Technologies Ltd.
 Sol-Gel Technologies Ltd. Pharmaceuticals: MajorHealth Technology Engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases | Health Technology |
InterCure Ltd.
 InterCure Ltd. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
Medica Venture Partners
Medica Venture Partners Investment ManagersFinance Medica Ventures Partners invests in public and private companies located in Israel, Europe and the United States. The firm focuses on health care and life science technologies from medical devices to pharmaceuticals, biotech and genomics sectors. It provides financing for seed and early stage capital requirements. | Finance |
Collgard Biopharmaceuticals Ltd.
 Collgard Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures tissue therapeutics | Health Technology |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases | Health Technology |
Vidyatel Ltd.
 Vidyatel Ltd. Information Technology ServicesTechnology Services Develops video-based content monitoring system | Technology Services |
Regentis Biomaterials Ltd.
 Regentis Biomaterials Ltd. BiotechnologyHealth Technology Develops proprietary hydrogels for tissue regeneration | Health Technology |
Gardia Medical Ltd.
 Gardia Medical Ltd. Medical SpecialtiesHealth Technology Develops catheter based delivery systems | Health Technology |
The Tel Aviv Stock Exchange (Investment Management)
 The Tel Aviv Stock Exchange (Investment Management) Investment Banks/BrokersFinance Provides fund management services | Finance |
Allmed Solutions Ltd.
 Allmed Solutions Ltd. Pharmaceuticals: OtherHealth Technology Develops medicinal coatings for implantable medical devices | Health Technology |
PainReform Ltd.
 PainReform Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceuticals for pain treatment | Health Technology |
Wyeth Laboratories, Inc. | |
Zori Medica 3 Ltd. | |
Zori Medica (2010) Ltd. | |
Tzory Medica (Management) Israel Ltd. | |
A.G. Arhimedes Ltd. | |
Zori Medica (Management) Israel Ltd. | |
A.D. Geller Enterprises Ltd. |
